Print

PEACHI-04

NCT02362217

Trial Details:

I Ongoing
University of Oxford; ReiThera Srl; GlaxoSmithKline
ChAdV63.HIVconsv ,MVA.HIVconsv
Healthy adults
RandD/trials/Lists/ClinicalTrialsList
8/1/2016
ChimpAd63 consensus; MVA consensus; AdCh3NSmut1; MVA-NSmut
AdCh3NSmut1 2.5 x 10^10 vp at week 0 and 1 dose MVA-NSmut 2 x 10^8 pfu at week 8. OR ChAdV63.HIVconsv 5 x 10^10 vp at week 0 and 1 dose MVA.HIVconsv 2 x 10^8 pfu at week 8. OR AdCh3NSmut1 2.5 x 10^10 vp and 1 dose ChAdV63.HIVconsv 5 x 10^10 vp at week 0,